Donald L. Hagan LLC Cuts Stake in The Clorox Company (NYSE:CLX)

Donald L. Hagan LLC reduced its stake in The Clorox Company (NYSE:CLX) by 4.7% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 10,190 shares of the company’s stock after selling 499 shares during the quarter. Clorox accounts for approximately 0.9% of Donald L. Hagan LLC’s portfolio, making the stock its 22nd largest holding. Donald L. Hagan LLC’s holdings in Clorox were worth $1,655,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Crews Bank & Trust bought a new stake in shares of Clorox during the fourth quarter valued at about $191,000. Swedbank AB increased its position in shares of Clorox by 16.9% during the fourth quarter. Swedbank AB now owns 48,984 shares of the company’s stock valued at $7,955,000 after buying an additional 7,068 shares during the period. Robeco Institutional Asset Management B.V. increased its position in shares of Clorox by 49.0% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 370,880 shares of the company’s stock valued at $60,235,000 after buying an additional 121,979 shares during the period. IRON Financial LLC increased its position in shares of Clorox by 2.8% during the fourth quarter. IRON Financial LLC now owns 5,512 shares of the company’s stock valued at $895,000 after buying an additional 151 shares during the period. Finally, Slow Capital Inc. increased its position in shares of Clorox by 0.8% during the fourth quarter. Slow Capital Inc. now owns 18,462 shares of the company’s stock valued at $2,998,000 after buying an additional 142 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CLX has been the topic of several analyst reports. Barclays decreased their price target on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research report on Friday, January 17th. DA Davidson boosted their price objective on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a report on Thursday. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and boosted their price objective for the stock from $155.00 to $157.00 in a report on Tuesday, January 7th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $156.07.

Clorox Price Performance

CLX opened at $160.28 on Friday. The stock has a 50-day moving average price of $163.15 and a 200-day moving average price of $158.01. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The firm has a market cap of $19.84 billion, a PE ratio of 55.85, a P/E/G ratio of 2.92 and a beta of 0.42. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the company earned $0.49 EPS. Clorox’s revenue for the quarter was up 27.0% on a year-over-year basis. Sell-side analysts predict that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.04%. Clorox’s dividend payout ratio is currently 170.04%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.